TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Charles & Colvard ( (CTHR) ) has shared an update.
On June 24, 2025, Charles & Colvard entered into a Convertible Secured Note Purchase Agreement with Ethara Capital LLC for $2.0 million, structured in two tranches. This agreement grants Ethara Capital the right to appoint directors and observers to Charles & Colvard’s board, while the company secures the note with its assets. The deal, subject to shareholder approval, allows for conversion into common stock and includes waivers of severance benefits by the company’s CEO and CFO, indicating a strategic move to strengthen its financial position and governance.
Spark’s Take on CTHR Stock
According to Spark, TipRanks’ AI Analyst, CTHR is a Underperform.
The overall stock score reflects severe financial challenges, poor valuation, and the negative impact of the Nasdaq delisting. The most significant factors are the company’s financial instability, evidenced by persistent losses and cash flow issues, combined with the risk of delisting, which severely affects investor confidence and stock liquidity. Technical analysis also indicates a bearish trend, further contributing to the low score.
To see Spark’s full report on CTHR stock, click here.
More about Charles & Colvard
Charles & Colvard, Ltd. operates in the jewelry industry, focusing on the production and sale of moissanite gemstones and jewelry. The company is known for its innovative approach to creating sustainable and ethically sourced gemstones.
Average Trading Volume: 61,277
Technical Sentiment Signal: Sell
Current Market Cap: $1.12M
For an in-depth examination of CTHR stock, go to TipRanks’ Overview page.